These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

872 related items for PubMed ID: 16249481

  • 1. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, Yang W, Jiang A, Kuang W, Xu L, Chen J, Liu Z.
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [Abstract] [Full Text] [Related]

  • 2. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.
    Li C, Li L, Cheng R, Dai Z, Li C, Yao Y, Zhou T, Yang Z, Gao G, Yang X.
    Cornea; 2013 May; 32(5):680-8. PubMed ID: 23343948
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
    Wang Y, Yin H, Chen P, Xie L, Wang Y.
    Ophthalmic Res; 2011 May; 46(2):66-72. PubMed ID: 21242701
    [Abstract] [Full Text] [Related]

  • 4. Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium.
    Conners MS, Urbano F, Vafeas C, Stoltz RA, Dunn MW, Schwartzman ML.
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1963-71. PubMed ID: 9331260
    [Abstract] [Full Text] [Related]

  • 5. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
    Zhou AY, Bai YJ, Zhao M, Yu WZ, Li XX.
    Ophthalmic Res; 2013 Sep; 50(3):180-6. PubMed ID: 24008241
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC, Yang LC, Kuo HK, Huang CC, Tsai CL, Lin PR, Wu PC, Shin SJ, Tai MH.
    Mol Vis; 2005 Jan 13; 11():28-35. PubMed ID: 15660022
    [Abstract] [Full Text] [Related]

  • 7. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
    Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, Shimmura S, Tsubota K, Amano S, Kawakami Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2008 May 13; 49(5):2172-7. PubMed ID: 18263815
    [Abstract] [Full Text] [Related]

  • 8. Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis.
    Cheng HC, Yeh SI, Tsao YP, Kuo PC.
    Mol Vis; 2007 Dec 30; 13():2344-52. PubMed ID: 18199977
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
    Kwon YS, Hong HS, Kim JC, Shin JS, Son Y.
    Invest Ophthalmol Vis Sci; 2005 Feb 30; 46(2):454-60. PubMed ID: 15671269
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
    Sari ES, Yazici A, Aksit H, Yay A, Sahin G, Yildiz O, Ermis SS, Seyrek K, Yalcin B.
    Curr Eye Res; 2015 Jan 30; 40(1):48-55. PubMed ID: 24910898
    [Abstract] [Full Text] [Related]

  • 13. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL, Lin CT, Lin NT, Tu IH, Li JW, Chow LP, Liu KR, Hu FR.
    Invest Ophthalmol Vis Sci; 2009 Apr 30; 50(4):1659-65. PubMed ID: 18997093
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops.
    Jin J, Ma JX, Guan M, Yao K.
    Cornea; 2010 Sep 30; 29(9):1055-61. PubMed ID: 20539216
    [Abstract] [Full Text] [Related]

  • 15. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model.
    Gore A, Horwitz V, Cohen M, Gutman H, Cohen L, Gez R, Kadar T, Dachir S.
    Exp Eye Res; 2018 Jun 30; 171():183-191. PubMed ID: 29548928
    [Abstract] [Full Text] [Related]

  • 16. Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model.
    Kubota M, Shimmura S, Kubota S, Miyashita H, Kato N, Noda K, Ozawa Y, Usui T, Ishida S, Umezawa K, Kurihara T, Tsubota K.
    Invest Ophthalmol Vis Sci; 2011 Jan 21; 52(1):427-33. PubMed ID: 20847117
    [Abstract] [Full Text] [Related]

  • 17. Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.
    Qiu F, Shin Y, Chen D, Cheng R, Chen Q, Zhou K, Larrick JW, Mendelson AR, Ma JX.
    Microvasc Res; 2018 Sep 21; 119():29-37. PubMed ID: 29630973
    [Abstract] [Full Text] [Related]

  • 18. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects.
    Su W, Li Z, Li Y, Lin M, Yao L, Liu Y, He Z, Wu C, Liang D.
    Invest Ophthalmol Vis Sci; 2011 Nov 25; 52(12):9108-15. PubMed ID: 22039247
    [Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X, Ottino P, Bazan HE, Bazan NG.
    Invest Ophthalmol Vis Sci; 2004 Sep 25; 45(9):2915-21. PubMed ID: 15326102
    [Abstract] [Full Text] [Related]

  • 20. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
    Zuo L, Fan Y, Wang F, Gu Q, Xu X.
    Curr Eye Res; 2010 May 25; 35(5):375-84. PubMed ID: 20450250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.